During the past decade, Blair Medical Associates Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blair Medical Associates Inc." #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Eisai Inc." with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored, "Analgesic Solutions" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blair Medical Associates Inc." #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Astellas Pharma Europe B.V." with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Blair Medical Associates Inc." are "Diabetes Mellitus, Type 2" (3 trials), "Diabetes" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Blair Medical Associates Inc." in a lesser frequency.

Most popular intervention types in "Blair Medical Associates Inc." are "Drug" (12 trials), "Behavioral" (2 trials), "Device" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Metformin" (2 trials), "Apixaban" (1 trials), "Current standard of care insole" (1 trials) and "Diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blair Medical Associates Inc." are 16 trials for "All" genders.

Currently, there are NaN active trials in "Blair Medical Associates Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Blair Medical Associates Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Blair Medical Associates Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".